Stock Yearly Return 2017
Start date: 01/03/2017
End date: 12/29/2017
Start price/share: $14.50
End price/share: $13.80
Dividends collected/share: $0.00
Total return: -4.83%
PSTI Average Annual Return: -4.89%
Starting investment: $10,000.00
Ending investment: $9,517.00
Years: 0.99


PSTI average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare PSTI average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into PSTI


Also see:
PSTI stock yearly return 2018
PSTI stock yearly return 2019
PSTI stock yearly return 2020
PSTI YTD return
PSTI average annual return 10 years
Pluristem Therapeutics is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Co.'s product candidates include: placenta expanded (PLX)-peripheral arterial disease, which is in a multinational clinical trial in critical limb ischemia, in recovery following surgery for hip fracture, and in the treatment of severe coronavirus-19 cases complicated by Acute Respiratory Distress Syndrome (ARS); and PLX-R18, which is under development in the United States for ARS, as well as in a trial in the United States and Israel for incomplete hematopoietic recovery following hematopoietic cell transplantation. The PSTI stock yearly return is shown above.

The yearly return on the PSTI stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2017 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the PSTI annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for PSTI:
PSTI SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pluristem Therapeutics (PSTI) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

PTCT Average Annual Return
PTGX Average Annual Return
PTI Average Annual Return
PTIE Average Annual Return
PTLA Average Annual Return
PTX Average Annual Return
PULM Average Annual Return
QDEL Average Annual Return
QGEN Average Annual Return
QHC Average Annual Return
More Healthcare companies »

 

PSTI Stock Yearly Return 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.